About Us

Invivotek offers custom & standard pre-clinical services for NASH studies.  We help clients study mechanism of action, evaluate potential target genes and explore drug efficacy biomarkers.

Genesis Drug Discovery & Development (GD3) is a fully integrated CRO.

  • Discovery Biology, Hit to Lead and Lead Optimization
  • Synthetic Organic & Medicinal Chemistry (including IND and IP support)
  • In vitro ADME
  • Assay and Biomarker development
  • Recombinant Protein Expression/Purification
  • DMPK/in-vivo pharmacology & GLP Toxicology


Our clients span a wide range of therapeutic areas including oncology, ophthalmology, inflammation/autoimmunity, metabolic diseases, gene therapy, RNA targets and microbiome.

Team Members

douglee headshot

Doug Lee, PhD

Business Development Manager


Michael Hayward

Assistant Director, Invivotek